NTRK3 and breast carcinoma: ETV6-NTRK3, which had been identified as a causative fusion oncogene in over 90% of secretary breast cancer samples, encodes a dimerization domain of the ETV6 transcription factor, conjoined to kinase domain of NTRK3 [15].